• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物使用障碍治疗药物确实能帮助患者。

Medications for Opioid Use Disorder Do Help Patients.

机构信息

Emergency Department of Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri.

出版信息

Mo Med. 2022 May-Jun;119(3):271-276.

PMID:36035557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9324703/
Abstract

Much of the focus on the current opioid crisis remains on how we arrived here and who is to blame. Despite having effective treatments for the management of patients with opioid use disorder (OUD), rates of overdose deaths continue to increase. As such, the focus needs to shift to increasing access to medications for OUD and better incorporation of harm reduction strategies to decrease not just the mortality but also the morbidity associated with OUD and other substance use disorders. Unfortunately, significant barriers rooted in misunderstanding and bias still limit access and prevent patients with OUD from seeking and staying in treatment. Until these are overcome and medical practice changes, both physicians and patients will continue to struggle to overcome this problem.

摘要

当前阿片类药物危机的重点主要集中在我们是如何走到这一步的,以及应该责怪谁。尽管我们有治疗阿片类药物使用障碍(OUD)患者的有效方法,但过量用药死亡人数仍在继续上升。因此,重点需要转移到增加阿片类药物使用障碍药物的可及性,以及更好地纳入减少伤害策略,不仅降低与阿片类药物使用障碍和其他物质使用障碍相关的死亡率,还要降低发病率。不幸的是,由于误解和偏见而导致的严重障碍仍然限制了药物的获取,并阻止了阿片类药物使用障碍患者寻求和接受治疗。在这些障碍得到克服,医疗实践发生改变之前,医生和患者都将继续努力克服这个问题。

相似文献

1
Medications for Opioid Use Disorder Do Help Patients.阿片类药物使用障碍治疗药物确实能帮助患者。
Mo Med. 2022 May-Jun;119(3):271-276.
2
Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.系统评价针对美国阿片类药物流行的国家政策干预措施,2007-2018 年。
JAMA Netw Open. 2021 Feb 1;4(2):e2036687. doi: 10.1001/jamanetworkopen.2020.36687.
3
Development of a Cascade of Care for responding to the opioid epidemic.开发一个应对阿片类药物流行的护理级联。
Am J Drug Alcohol Abuse. 2019;45(1):1-10. doi: 10.1080/00952990.2018.1546862. Epub 2019 Jan 24.
4
News Media Reporting On Medication Treatment For Opioid Use Disorder Amid The Opioid Epidemic.新闻媒体在阿片类药物流行期间对阿片类药物使用障碍的药物治疗进行报道。
Health Aff (Millwood). 2019 Apr;38(4):643-651. doi: 10.1377/hlthaff.2018.05075.
5
Opioid use disorder: current trends and potential treatments.阿片类药物使用障碍:当前趋势和潜在治疗方法。
Front Public Health. 2024 Jan 25;11:1274719. doi: 10.3389/fpubh.2023.1274719. eCollection 2023.
6
Opioid Use Disorder and Overdose in the First Year Postpartum: A Rapid Scoping Review and Implications for Future Research.产后第一年的阿片类药物使用障碍和过量:快速范围审查及对未来研究的启示。
Matern Child Health J. 2023 Jul;27(7):1140-1155. doi: 10.1007/s10995-023-03614-7. Epub 2023 Feb 25.
7
Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.具有高阿片类药物过量死亡率和提供阿片类药物使用障碍治疗能力低的美国县的特征。
JAMA Netw Open. 2019 Jun 5;2(6):e196373. doi: 10.1001/jamanetworkopen.2019.6373.
8
Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US.建模减轻策略以减少美国阿片类药物相关发病率和死亡率。
JAMA Netw Open. 2020 Nov 2;3(11):e2023677. doi: 10.1001/jamanetworkopen.2020.23677.
9
Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.监禁人员中与阿片类药物相关的治疗、干预措施和结果:系统评价。
PLoS Med. 2019 Dec 31;16(12):e1003002. doi: 10.1371/journal.pmed.1003002. eCollection 2019 Dec.
10
Assessing Opioid Use Disorder Treatments in Trials Subject to Non-Adherence via a Functional Generalized Linear Mixed-Effects Model.通过功能广义线性混合效应模型评估试验中受非依从性影响的阿片类物质使用障碍治疗方法。
Int J Environ Res Public Health. 2022 Apr 29;19(9):5456. doi: 10.3390/ijerph19095456.

本文引用的文献

1
Supervised Injection Facilities as Harm Reduction: A Systematic Review.监督注射设施作为减少伤害的措施:系统评价。
Am J Prev Med. 2021 Nov;61(5):738-749. doi: 10.1016/j.amepre.2021.04.017. Epub 2021 Jul 1.
2
Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019.2013-2019 年美国药物和合成阿片类药物过量死亡的趋势和地理模式。
MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):202-207. doi: 10.15585/mmwr.mm7006a4.
3
Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review.阿片类物质使用障碍药物治疗的障碍与促进因素:快速综述
J Gen Intern Med. 2020 Dec;35(Suppl 3):954-963. doi: 10.1007/s11606-020-06257-4. Epub 2020 Nov 3.
4
Trends in Buprenorphine Treatment in the United States, 2009-2018.2009-2018 年美国丁丙诺啡治疗趋势。
JAMA. 2020 Jan 21;323(3):276-277. doi: 10.1001/jama.2019.18913.
5
Predictors for 30-Day and 90-Day Hospital Readmission Among Patients With Opioid Use Disorder.阿片类药物使用障碍患者 30 天和 90 天内住院再入院的预测因素。
J Addict Med. 2019 Jul/Aug;13(4):306-313. doi: 10.1097/ADM.0000000000000499.
6
Role of the Hospital in the 21st Century Opioid Overdose Epidemic: The Addiction Medicine Consult Service.21 世纪阿片类药物过量流行中的医院作用:成瘾医学咨询服务。
J Addict Med. 2019 Mar/Apr;13(2):104-112. doi: 10.1097/ADM.0000000000000496.
7
The First Comprehensive Program for Opioid Use Disorder in a US Statewide Correctional System.美国全州惩教系统首个阿片类药物使用障碍综合项目。
Am J Public Health. 2018 Oct;108(10):1323-1325. doi: 10.2105/AJPH.2018.304666.
8
Primary Care and the Opioid-Overdose Crisis - Buprenorphine Myths and Realities.初级保健与阿片类药物过量危机——丁丙诺啡的误区与真相
N Engl J Med. 2018 Jul 5;379(1):1-4. doi: 10.1056/NEJMp1802741.
9
Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System.在全州监狱系统实施药物成瘾治疗后,监禁后的致命过量。
JAMA Psychiatry. 2018 Apr 1;75(4):405-407. doi: 10.1001/jamapsychiatry.2017.4614.
10
Why aren't physicians prescribing more buprenorphine?为什么医生没有开出更多的丁丙诺啡?
J Subst Abuse Treat. 2017 Jul;78:1-7. doi: 10.1016/j.jsat.2017.04.005. Epub 2017 Apr 12.